Published on 12 Mar 2024 on Investing.com
Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX ) has revealed findings from a post hoc analysis of its inTandem3 Phase 3 trial, indicating ...
Start tracking your investments with Statfolio
Lexicon Pharmaceuticals, Inc. LXRX announced data from a new post hoc analysis of its phase III i...
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points o...
Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX ) has revealed findings from a post hoc analysis of ...
Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump
Shares of Mesoblast Limited MESO rose sharply during Monday’s session after the company announce...
Lexicon Pharmaceuticals , Inc. (NASDAQ: LXRX ) announced today it has entered into a securities...
Key Insights Lexicon Pharmaceuticals' significant private equity firms ownership suggests that th...
Recent insider trading activity has caught the attention of market analysts and investors alike, ...
The Dow Jones closed higher by over 50 points on Monday. When insiders purchase or sell shares, i...